000			02106 a2200553 4500
005			20250514035439.0
264		0	_c20020816
008			200208s 0 0 eng d
022			_a0014-4886
024	7		_a10.1006/exnr.2002.7912 _2doi
040			_aNLM _beng _cNLM
100	1		_aArias, Clorinda
245	0	0	_abeta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease. _h[electronic resource]
260			_bExperimental neurology _cJul 2002
300			_a163-74 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenosine Triphosphate _xmetabolism
650	0	4	_aAlzheimer Disease _xdrug therapy
650	0	4	_aAmyloid beta-Peptides _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aDisease Models, Animal
650	0	4	_aDizocilpine Maleate _xpharmacology
650	0	4	_aEnergy Metabolism _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aGlucose _xmetabolism
650	0	4	_aGlycolysis _xdrug effects
650	0	4	_aHippocampus _xchemistry
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aIodoacetates _xpharmacology
650	0	4	_aMale
650	0	4	_aMicroinjections
650	0	4	_aMitochondria _xchemistry
650	0	4	_aNeocortex _xchemistry
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aNitro Compounds
650	0	4	_aPeptide Fragments _xadministration & dosage
650	0	4	_aPresynaptic Terminals _xchemistry
650	0	4	_aPropionates _xpharmacology
650	0	4	_aPyruvic Acid _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aSynaptosomes _xchemistry
700	1		_aMontiel, Teresa
700	1		_aQuiroz-Báez, Ricardo
700	1		_aMassieu, Lourdes
773	0		_tExperimental neurology _gvol. 176 _gno. 1 _gp. 163-74
856	4	0	_uhttps://doi.org/10.1006/exnr.2002.7912 _zAvailable from publisher's website
999			_c11987196 _d11987196